Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Tech · Services-Computer Integrated Systems Design

MDaudit to acquire Streamline Health Solutions Inc.

Announced May 29, 2025 · Closed Aug 12, 2025

Deal value$37MEV $29M
Premium138.0%To unaffected price
EV / Adj. EBITDA—1.6x EV / Revenue
ConsiderationAll cash$5.34 per share

Transaction

Acquirer
MDaudit
Target
Streamline Health Solutions Inc. (STRM)
Buyer type
Strategic
Offer price per share
$5.34
Enterprise value
$29M
Status
Closed Aug 12, 2025

Deal protections

Break fee (target pays)
$0.9M · 2.5%
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
Cain Brothers, KeyBanc Capital Markets

Sector context · Tech

Comparable deals
60 in the prior 24 months
Premium
138.0% vs. 37.0% sector median
EV / Adj. EBITDA
Sector median 16.7x
Break fee
2.5% vs. 3.1% sector median

Timeline

  1. AnnouncedMay 29, 2025
  2. Proxy filedJun 30, 2025
  3. Definitive proxyJul 10, 2025
  4. Shareholder voteAug 7, 2025
  5. ClosedAug 12, 2025

Valuation · fairness opinions

Trading comparables$2.90$4.96
Trading comparables$3.03$5.12
Trading comparables$4.96$7.01
Discounted cash flow$2.20$3.66
Premiums paid$2.69$3.60
Offer $5.34

Implied value per Streamline Health Solutions Inc. share by analysis, from Cain Brothers · DCF discount rate 16.9%–18.9%.

Sources
  • 8-K (EX-99.1) · May 29, 2025
  • DEFA14A (EX-99.1) · May 29, 2025

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.